Keio University

Press Release

461-470 items (total 1560)
Published At April 27, 2023

Possibility of Reducing Methotrexate, a Key Drug in Rheumatoid Arthritis Treatment, Revealed—A Trial on Methotrexate Dose Reduction When Initiating a Biologic Agent

Published At April 26, 2023

Keio University and READYFOR Announce Business PartnershipFirst Collaborative Project Launched—Project: "Accelerating Research to Overcome ALS: A Fusion of Basic and Clinical Research for Neurodegenerative Diseases"—

Published At April 25, 2023

Elucidating the Role of Innate Immune Cells in Severe COVID-19: An Integrated Analysis of Single-Cell and Genomic Information

Published At April 25, 2023

Development of a Model to Simulate Antibody Titer Trends after COVID-19 Vaccination

Published At April 25, 2023

World's First Successful Development of an Ultra-thin, Disposable Endoscope as Fine as a Hypodermic Needle Using Graded-Index Plastic Optical Fiber (GI-POF) Technology—Facilitating pre-arthroscopic surgery examinations and post-operative follow-up

Published At April 18, 2023

Yukichi Fukuzawa-Francis Wayland Memorial Lecture (May 15)"War, Success, and Gender: The Foundational Process of Meiji Japan" by Yusaku Matsuzawa, Professor, Faculty of Economics, Keio University

Published At April 18, 2023

Discovery of a Pathogenic *BRCA2* Gene Variant Specific to the Japanese Population, a Causative Gene for Hereditary Breast and Ovarian Cancer—Expectations for the Implementation of Personalized Medicine Based on Genomic Information—

Published At April 17, 2023

Saga Prefecture and Keio University Graduate School of Media Design (KMD) Launch Social Demonstration Project to Realize a Sustainable Local Community- Developing Demonstration Projects Aimed at Cross-Disciplinary Problem Solving by Connecting Companies, Residents, and Governments Inside and Outside Saga Prefecture -

Published At April 14, 2023

Research on the Realities of Telework and Workers Amid the Spread of COVID-19 (Preliminary Report on the 9th Survey on Telework Realities for Workers)

Published At April 14, 2023

MHLW Grants Priority Review to Support Program for Screening of Depression / Rating of Severity "SWIFT" (tentative name) as First Software as a Medical Device (SaMD)